Search Results 2701-2710 of 111937 for Cells

1. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

   ... Cell Cancer. Print details. Share ... Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

2. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

   The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...

3. Mayo Clinic researchers identify how fat stores in the liver provide an energy source during fasting

   But, in a starving cell, the normal pathway switches off, and a recycling process, called autophagy, switches on. Autophagy is a way for cells to break down ...

4. Center for Regenerative Biotherapeutics - Clinical translation

   Cancer — hematologic, CAR-T cell therapy, Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells in Subjects ...

5. Carcinoma Clinical Trials - Mayo Clinic Research

   Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This ...

6. Adrenal cancer - Diagnosis and treatment - Mayo Clinic

   Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells find and kill the cancer cells. For adrenal cancer ...

7. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

   ... cell lymphoma (MCL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

8. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer ... cells in resected tumor and lymph nodes. To assess ...

9. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

   Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, ...

10. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

    A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies. Print details. Share; Facebook · Twitter.